StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CorMedix's pe ratio was 2.2× on Nov 11, 2026, against 4.7× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−3.4
2025Dec 31, 20255.6×–

More CorMedix figures

See a number that looks wrong?